Semaglutide
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Novo Nordisk · Phase 3 · Completed · Enrollment 407
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| semaglutide 2.4 mg | Obesity or overweight | 2.4 mg | n/r | ITT | n/r |
| semaglutide 2.4 mg (placebo) | Obesity or overweight | 2.4 mg | n/r | ITT | n/r |